Nutraceutical Renews Ephedra Case In Utah Court; FDA To Respond By Jan. 18

FDA did not provide advance notice and opportunity for public comment when it "created a new adulteration standard" in its 2004 final rule banning ephedra alkaloids in dietary supplements, Nutraceutical argues in a motion renewing its case against FDA

More from Archive

More from Pink Sheet